Equivalent Dose of Solu-Medrol to Omnacortil
Methylprednisolone (Solu-Medrol) is approximately 1.25 times more potent than prednisolone (Omnacortil), meaning 4 mg of methylprednisolone equals 5 mg of prednisolone. 1
Standard Conversion Ratio
- The established conversion is 4 mg methylprednisolone = 5 mg prednisolone/prednisone, based on anti-inflammatory potency equivalence 1
- Methylprednisolone is 5 times more potent than hydrocortisone, while prednisolone is 4 times more potent than hydrocortisone, yielding the 1.25:1 ratio 1
- This ratio applies to both oral and intravenous formulations, as both drugs have excellent bioavailability 1
Practical Conversion Examples
- Omnacortil 5 mg = Solu-Medrol 4 mg 1
- Omnacortil 25 mg = Solu-Medrol 20 mg 1
- Omnacortil 60 mg = Solu-Medrol 48 mg 1
- Omnacortil 75 mg = Solu-Medrol 60 mg 2
Route-Specific Considerations
When Converting Oral to IV
- The 1.25:1 ratio remains valid because both oral formulations have excellent bioavailability and rapid absorption 1
- For grade 3-4 toxicities requiring IV therapy, administer IV methylprednisolone 1-2 mg/kg, which equals oral prednisone 1.25-2.5 mg/kg 1
- IV methylprednisolone provides more rapid therapeutic effect and higher peak concentrations, making it preferred for severe disease flares 3
Transitioning from IV Pulse to Oral Maintenance
- After IV methylprednisolone pulse therapy (500-1000 mg daily for 1-3 days), transition to oral prednisone at 0.5-1 mg/kg/day (maximum 60 mg/day) 2
- Use the same 1:1.25 conversion ratio when switching from IV methylprednisolone to oral prednisolone 2
- Taper oral prednisolone gradually over 3-6 months depending on clinical response 2
Pharmacokinetic Differences That Matter Clinically
- Methylprednisolone exhibits linear, dose-independent pharmacokinetics, making dosing more predictable 4
- Prednisolone shows marked dose-dependent pharmacokinetics with saturable protein binding, resulting in higher clearance at higher doses 4, 5
- Methylprednisolone has 77% protein binding that is linear and non-saturable 5
- Prednisolone binds to transcortin (corticosteroid-binding globulin), which becomes saturated at higher doses, complicating dose predictions 4, 5
Clinical Advantages of Each Agent
Methylprednisolone Advantages
- More predictable pharmacokinetics because concentrations are proportional to dose without need for protein binding determination 4
- Greater anti-inflammatory potency than prednisolone with less tendency to induce sodium and water retention 6
- Preferred for pulse therapy in severe autoimmune conditions due to more rapid onset 7
Prednisolone Advantages
- Oral formulation is widely available and less expensive
- Suitable for maintenance therapy after initial pulse treatment 2
Common Pitfalls and Caveats
- Do not confuse methylprednisolone with methylprednisone—they are different compounds 1
- When converting from high-dose pulse therapy to oral maintenance, avoid underdosing by carefully applying the 1.25:1 ratio 2
- Prednisolone's dose-dependent pharmacokinetics make it extremely difficult to determine the exact dose needed for a desired target concentration, especially at higher doses 4
- Both agents require identical bone protection measures: calcium and vitamin D supplementation with bisphosphonates for patients taking prednisone ≥7.5 mg daily (or methylprednisolone ≥6 mg daily) for ≥3 months 1
- Monitor blood glucose during conversion, especially when using higher doses, as hyperglycemic effects peak 6-9 hours post-administration 2
High-Dose Pulse Therapy Context
- For pulse therapy, methylprednisolone 500-1000 mg IV daily for 1-3 days is standard for severe autoimmune conditions 2
- The American College of Rheumatology defines high-dose pulse glucocorticoids as ≥10 mg/kg/day methylprednisolone equivalent 8
- High-dose oral glucocorticoids are defined as ≥2 mg/kg/day prednisone equivalent 8
- After pulse therapy, transition to oral prednisone 0.5-1 mg/kg/day using the conversion ratio 2